Home Covid-19 Pfizer Says Tweaked COVID-19 Shots Boost Omicron Protection

Pfizer Says Tweaked COVID-19 Shots Boost Omicron Protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.

The vaccines currently used in the U.S. still offer strong protection against severe COVID-19 disease and death — especially if people have gotten a booster dose. But those vaccines target the original coronavirus strain and their effectiveness against any infection dropped markedly when the super-contagious omicron mutant emerged.

Now with omicron’s even more transmissible relatives spreading widely, the Food and Drug Administration is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another COVID-19 surge expected this fall and winter.


FILE – A vial of the Pfizer-BioNTech COVID-19 vaccine for children 5 to 12 years old sits ready for use at a vaccination site in Fort Worth, Texas, Nov. 11, 2021.

Pfizer and its partner BioNTech studied two different ways of updating their shots— targeting just omicron, or a combination booster that adds omicron protection to the original vaccine. They also tested whether to keep today’s standard dosage — 30 micrograms— or to double the shots’ strength.

In a study of more than 1,200 middle-aged and older adults who’d already had three vaccine doses, Pfizer said both booster approaches spurred a substantial jump in omicron-fighting antibodies.

“Based on these data, we believe we have two very strong omicron-adapted candidates,” Pfizer CEO Albert Bourla said in a statement.

Pfizer’s omicron-only booster sparked the strongest immune response against that variant.

But many experts say combination shots may be the best approach because they would retain the proven benefits of the original COVID-19 vaccine while adding new protection against omicron. And Pfizer said a month after people received its combo shot, they had a nine to elevenfold increase in omicron-fighting antibodies. That’s more than 1.5 times better than another dose of the original vaccine.

And importantly, preliminary lab studies show the tweaked shots also produce antibodies capable of fighting omicron’s genetically distinct relatives named BA.4 and BA.5, although those levels weren’t nearly as high.


FILE – In this March 4, 2021, photo, a vial of the Moderna COVID-19 vaccine rests on a table at a drive-up mass vaccination site in Puyallup, Wash.

Moderna recently announced similar results from tests of its combination shot, what scientists call a “bivalent” vaccine.

The studies weren’t designed to track how well updated boosters prevented COVID-19 cases. Nor is it clear how long any added protection would last.

But the FDA’s scientific advisers will publicly debate the data Tuesday, as they grapple with whether to recommend a change to the vaccines’ recipes — ahead of similar decisions by other countries.

Most Popular

Comment on Washington state agrees to dismiss meal/rest break appeal by Matthew

The state of Washington agreed last week to dismiss an appeal of a decision that found the state’s truck driver meal and rest break...

Comment on Feds drop fraud charges against Celadon trucking executives by Chris

Federal prosecutors on Wednesday dropped a fraud case alleging two former executives at Celadon Group devised a scheme that cost the truckload and logistics...

Levin on Trump raid: ‘Who lost track of these classified documents?’

NEWYou can now listen to Fox News articles! Mark Levin, host of "Life, Liberty & Levin" reacted to news of the findings in...

Criminal case against Trump Organization and ex-CFO Weisselberg can proceed, judge rules

A New York judge on Friday set an Oct. 24 trial date for the criminal case against the Trump Organization and its former chief...